Joshi M - Search Results

1

FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Warrick JI, Hu W, Yamashita H, Walter V, Shuman L, Craig JM, Gellert LL, Castro MAA, Robertson AG, Kuo F, Ostrovnaya I, Sarungbam J, Chen YB, Gopalan A, Sirintrapun SJ, Fine SW, Tickoo SK, Kim K, Thomas J, Karan N, Gao SP, Clinton TN, Lenis AT, Chan TA, Chen Z, Rao M, Hollman TJ, Li Y, Socci ND, Chavan S, Viale A, Mohibullah N, Bochner BH, Pietzak EJ, Teo MY, Iyer G, Rosenberg JE, Bajorin DF, Kaag M, Merrill SB, Joshi M, Adam R, Taylor JA 3rd, Clark PE, Raman JD, Reuter VE, Chen Y, Funt SA, Solit DB, DeGraff DJ, Al-Ahmadie HA. Warrick JI, et al. Among authors: joshi m. Nat Commun. 2022 Nov 2;13(1):6575. doi: 10.1038/s41467-022-34251-3. Nat Commun. 2022. PMID: 36323682 Free PMC article.

2

Immunotherapy in Bladder Cancer.

Vasekar M, Degraff D, Joshi M. Vasekar M, et al. Among authors: joshi m. Curr Mol Pharmacol. 2016;9(3):242-251. doi: 10.2174/1874467208666150716120945. Curr Mol Pharmacol. 2016. PMID: 26177642 Review.

3

Symptomatic Secondary Polycythemia Induced by Anti-VEGF Therapy for the Treatment of Metastatic Renal Cell Carcinoma: A Case Series and Review.

Wang W, Cheng J, Mallon C, Al-Marrawi MY, Holder S, Joshi M, Kaag M, Talamo G, Drabick JJ. Wang W, et al. Among authors: joshi m. Clin Genitourin Cancer. 2015 Dec;13(6):e391-5. doi: 10.1016/j.clgc.2015.07.003. Epub 2015 Jul 26. Clin Genitourin Cancer. 2015. PMID: 26303589 Review. No abstract available.

4

Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review.

Yin M, Wang W, Rosenberg J, Kaag M, Joshi M, Holder S, Tuanquin L, Drabick JJ. Yin M, et al. Among authors: joshi m. Clin Genitourin Cancer. 2016 Apr;14(2):e203-6. doi: 10.1016/j.clgc.2015.11.008. Epub 2015 Nov 17. Clin Genitourin Cancer. 2016. PMID: 26684811 Review. No abstract available.

5

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.

Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, Kaag M, Fransen van de Putte EE, Horenblas S, Drabick JJ. Yin M, et al. Among authors: joshi m. Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6. Oncologist. 2016. PMID: 27053504 Free PMC article. Review.

6

Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma.

Joshi M, Vasekar M, Grivas P, Emamekhoo H, Hsu J, Miller VA, Stephens PJ, Ali SM, Ross JS, Zhu J, Warrick J, Drabick JJ, Holder SL, Kaag M, Li M, Pal SK. Joshi M, et al. Oncotarget. 2016 Aug 9;7(32):52442-52449. doi: 10.18632/oncotarget.9449. Oncotarget. 2016. PMID: 27213592 Free PMC article.

7

Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.

Zaleski M, Gogoj A, Walter V, Raman JD, Kaag M, Merrill SB, Drabick J, Joshi M, Holder S, DeGraff DJ, Warrick JI. Zaleski M, et al. Among authors: joshi m. Hum Pathol. 2019 Feb;84:275-282. doi: 10.1016/j.humpath.2018.10.008. Epub 2018 Oct 22. Hum Pathol. 2019. PMID: 30359638

8

Need for a personalized approach for muscle invasive bladder cancer: role of tumor biology in response to neoadjuvant chemotherapy.

Joshi M, Warrick JI, Yin M, Holder SL, Drabick JJ. Joshi M, et al. Transl Androl Urol. 2019 Mar;8(Suppl 1):S99-S103. doi: 10.21037/tau.2018.12.04. Transl Androl Urol. 2019. PMID: 31143680 Free PMC article. No abstract available.

9

Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study.

Joshi M, Holder SL, Zhu J, Zheng H, Komanduri S, Warrick J, Yasin H, Garje R, Jia B, Drabick JJ, DeGraff DJ, Zakharia Y. Joshi M, et al. Eur Urol Focus. 2022 Mar;8(2):483-490. doi: 10.1016/j.euf.2021.03.005. Epub 2021 Mar 17. Eur Urol Focus. 2022. PMID: 33741296 Free PMC article. Clinical Trial.

10

Angelica gigas: Signature Compounds, In Vivo Anticancer, Analgesic, Neuroprotective and Other Activities, and the Clinical Translation Challenges.

Lü J, Jiang C, Schell TD, Joshi M, Raman JD, Xing C. Lü J, et al. Among authors: joshi m. Am J Chin Med. 2022;50(6):1475-1527. doi: 10.1142/S0192415X2250063X. Epub 2022 Jul 23. Am J Chin Med. 2022. PMID: 35876033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,243 results

Search Page